Table of Contents

• FDA RECEIVES NAS/NRC REPORT ON ANIMAL BIOTECHNOLOGY [ARCHIVED]
• FDA UNVEILS NEW INITIATIVE TO ENHANCE PHARMACEUTICAL GMP'S [ARCHIVED]
• REORGANIZATION WITHIN THE OFFICE OF NEW ANIMAL DRUG EVALUATION [ARCHIVED]
  by Joanne Kla
• CVM STAFF COLLEGE OPEN HOUSE [ARCHIVED]
  by Bobbie Giganti
• AAFCO ANNUAL MEETING 2002 [ARCHIVED]
  by Sharon Senesac
• THE SPREAD OF BSE IN SWITZERLAND-EPIDEMIOLOGY AND ONGOING ERADICATION OF A CHALLENGING DISEASE [ARCHIVED]
  by Lukas Perler, D.V.M.
• TREATING MINOR SPECIES: A MAJOR ANIMAL HEALTH CONCERN [ARCHIVED]
  by Linda Bren
• FIRST INTERNATIONAL CONFERENCE ON MICROBIAL RISK ASSESSMENT [ARCHIVED]
  by Gregg Claycamp, Ph.D.
• CVM WORKING WITH OECD ON REQUIREMENTS FOR BIOENGINEERED FOODS AND FEEDS [ARCHIVED]
  by William D. Price, Ph.D.
• THE USE OF STEROID HORMONES FOR GROWTH PROMOTION IN FOOD-PRODUCING ANIMALS [ARCHIVED]
• NEW CVM INTERNET SITE PROVIDES EA DOCUMENTS [ARCHIVED]
  by Raanan A. Bloom, Ph.D.
• REGULATORY ACTIVITIES - September/October 2002 [ARCHIVED]
  by Karen A. Kandra
• DRAFT VICH GUIDANCES AVAILABLE FOR REVIEW AND COMMENT [ARCHIVED]
• FDA PROPOSES NEW INDUSTRY DRAFT GUIDANCE FOR EVALUATING THE SAFETY OF ANTIMICROBIAL NEW ANIMAL DRUGS [ARCHIVED]
• ABBREVIATED NEW ANIMAL DRUG APPROVALS - September/October 2002 [ARCHIVED]
• NEW ANIMAL DRUG APPROVALS - September/October 2002 [ARCHIVED]
• SUPPLEMENTAL ABBREVIATED NEW ANIMAL DRUG APPROVALS - September/October 2002 [ARCHIVED]
• SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS - September/October 2002 [ARCHIVED]